McKesson Corporation (MCK) Return on Equity (ROE): -219.24%
Is McKesson Corporation’s return on equity (ROE) high or low?
McKesson Corporation's return on equity (ROE) of -219.24% is 106% below its 5-year average of 3473.86%, near the low end of its 5-year range (-219.24%–21614.29%).
As of Friday, June 19, 2026. 15.97% below its 12-month average of -189.06%.
MCK Return on Equity (ROE) Chart
MCK Average Return on Equity (ROE) Chart
MCK Current vs Average Return on Equity (ROE) Chart
MCK Return on Equity (ROE) Metrics
RETURN ON EQUITY (ROE)
-219.24%
RETURN ON EQUITY (ROE) AVG TTM
-189.06%
RETURN ON EQUITY (ROE) AVG 3Y
-180.53%
RETURN ON EQUITY (ROE) AVG 5Y
3473.86%
RETURN ON EQUITY (ROE) AVG 10Y
1903.08%
RETURN ON EQUITY (ROE) AVG 15Y
-26.63%
RETURN ON EQUITY (ROE) AVG 20Y
14.75%
CURRENT VS TTM AVG
-15.97%
CURRENT VS 3Y AVG
-21.44%
CURRENT VS 5Y AVG
-106.31%
CURRENT VS 10Y AVG
-111.52%
CURRENT VS 15Y AVG
-723.44%
CURRENT VS 20Y AVG
-1586.16%
MCK Competitors' Return on Equity (ROE)
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| McKesson Corporation (MCK) | $87.88B | -219.24% | -189.06% | -180.53% | 3473.86% |
| Elevance Health Inc. (ELV)vs › | $84.37B | 11.94% | 13.69% | 14.71% | 14.93% |
| HCA Healthcare, Inc. (HCA)vs › | $83.23B | -112.56% | -171.53% | -210.62% | -155.29% |
| Medtronic plc (MDT)vs › | $101.86B | 9.70% | 9.71% | 8.51% | 8.44% |
| Cigna Corporation (CI)vs › | $73.88B | 14.90% | 11.32% | 12.19% | 12.83% |
| Boston Scientific Corporation (BSX)vs › | $67.35B | 13.74% | 10.21% | 8.16% | 6.40% |
| Bristol-Myers Squibb Company (BMY)vs › | $110.27B | 36.25% | -8.30% | 7.76% | 4.45% |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $62.84B | 14.08% | 14.72% | 15.95% | 23.11% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $114.63B | 22.41% | 8.96% | 15.60% | 19.47% |
| Stryker Corporation (SYK)vs › | $119.03B | 14.52% | 14.50% | 15.05% | 14.30% |
Return Analysis
ROE
-219.2%
ROA
5.8%
McKesson Corporation Return on Equity (ROE) Formula & Definition
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
McKesson Corporation Return on Equity (ROE) FAQ
- What is the return on equity (ROE) for McKesson Corporation (MCK)?
- The return on equity (ROE) for MCK stock is -219.24%.
- Is McKesson Corporation's return on equity (ROE) high or low?
- McKesson Corporation's return on equity (ROE) of -219.24% is 106% below its 5-year average of 3473.86%, near the low end of its 5-year range (-219.24%–21614.29%).
- What is the TTM average return on equity (ROE) for McKesson Corporation (MCK)?
- The TTM average return on equity (ROE) for MCK stock is -189.06%.
- What is the 3Y average return on equity (ROE) for McKesson Corporation (MCK)?
- The 3Y average return on equity (ROE) for MCK stock is -180.53%.
- What is the 5Y average return on equity (ROE) for McKesson Corporation (MCK)?
- The 5Y average return on equity (ROE) for MCK stock is 3473.86%.
- What is the 10Y average return on equity (ROE) for McKesson Corporation (MCK)?
- The 10Y average return on equity (ROE) for MCK stock is 1903.08%.
- What is the 15Y average return on equity (ROE) for McKesson Corporation (MCK)?
- The 15Y average return on equity (ROE) for MCK stock is -26.63%.
- What is the 20Y average return on equity (ROE) for McKesson Corporation (MCK)?
- The 20Y average return on equity (ROE) for MCK stock is 14.75%.
McKesson Corporation Return on Equity (ROE) History
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-03-31 | -219.24% |
| 2025-03-31 | -158.87% |
| 2024-03-31 | -152.31% |
| 2023-03-31 | -191.71% |
| 2022-03-31 | -49.03% |
| 2021-03-31 | 21614.29% |
| 2020-03-31 | 17.67% |
| 2019-03-31 | 0.42% |
| 2018-03-31 | 0.68% |
| 2017-03-31 | 46.71% |
| 2016-03-31 | 25.30% |
| 2015-03-31 | 18.45% |
| 2014-03-31 | 14.82% |
| 2013-03-31 | 18.93% |
| 2012-03-31 | 20.54% |
| 2011-03-31 | 15.65% |
| 2010-03-31 | 16.77% |
| 2009-03-31 | 13.29% |
| 2008-03-31 | 16.17% |
| 2007-03-31 | 15.35% |
| 2006-03-31 | 12.49% |
| 2005-03-31 | -2.98% |
| 2004-03-31 | 12.52% |
| 2003-03-31 | 12.26% |
| 2002-03-31 | 10.62% |
| 2001-03-31 | -1.38% |
| 2000-03-31 | 20.30% |
| 1999-03-31 | 2.95% |
| 1998-03-31 | 11.01% |
| 1997-03-31 | 10.62% |
Related Metrics
About McKesson Corporation
McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Brian S. Tyler